Tautomer Bioscience has several marketed products in the South Africa through a network of commercial partners , in addition to a pipeline of late-stage candidates in clinical development.
Our product portfolio has a unique focus on unmet medical needs specifically in the areas of Oncology , Pain , Benign Gynaecology , and Urology At Tautomer, we are also expanding our focus in Rare Diseases.
Our company's strategy is to increase treatment options for HCPs and patients in emerging markets whilst enhancing access to quality healthcare through affordable health products.